View in EDS HTML Full Text PDF Full Text

Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S‐1 for neoadjuvant therapy of locally advanced gastric cancer with HER2‐overexpressing: Preliminary results of a prospective, single‐arm, phase II study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S‐1 for neoadjuvant therapy of locally advanced gastric cancer with HER2‐overexpressing: Preliminary results of a prospective, single‐arm, phase II study.
Authors: Wang, Longgang1 (AUTHOR), Liu, Bing1 (AUTHOR), Liu, Luguang1 (AUTHOR), Liu, Liqing1 (AUTHOR), Li, Rong2 (AUTHOR), Han, Shumei3 (AUTHOR), Sun, Xu1 (AUTHOR), Bi, Bo1 (AUTHOR), Sun, Yuanlin1 (AUTHOR), Sun, Dong1 (AUTHOR) dsun@email.sdfmu.edu.cn, Chai, Jie1 (AUTHOR) jchai@sdfmu.edu.cn
Source: Clinical & Translational Medicine. May2026, Vol. 16 Issue 5, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 194013401
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S‐1 for neoadjuvant therapy of locally advanced gastric cancer with HER2‐overexpressing: Preliminary results of a prospective, single‐arm, phase II study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wang%2C+Longgang%22">Wang, Longgang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Bing%22">Liu, Bing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Luguang%22">Liu, Luguang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Liqing%22">Liu, Liqing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Rong%22">Li, Rong</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Han%2C+Shumei%22">Han, Shumei</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Xu%22">Sun, Xu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bi%2C+Bo%22">Bi, Bo</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Yuanlin%22">Sun, Yuanlin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Dong%22">Sun, Dong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> dsun@email.sdfmu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Chai%2C+Jie%22">Chai, Jie</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> jchai@sdfmu.edu.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Translational+Medicine%22">Clinical & Translational Medicine</searchLink>. May2026, Vol. 16 Issue 5, p1-18. 18p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194013401
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ctm2.70679
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 18
        StartPage: 1
    Titles:
      – TitleFull: Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S‐1 for neoadjuvant therapy of locally advanced gastric cancer with HER2‐overexpressing: Preliminary results of a prospective, single‐arm, phase II study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang, Longgang
      – PersonEntity:
          Name:
            NameFull: Liu, Bing
      – PersonEntity:
          Name:
            NameFull: Liu, Luguang
      – PersonEntity:
          Name:
            NameFull: Liu, Liqing
      – PersonEntity:
          Name:
            NameFull: Li, Rong
      – PersonEntity:
          Name:
            NameFull: Han, Shumei
      – PersonEntity:
          Name:
            NameFull: Sun, Xu
      – PersonEntity:
          Name:
            NameFull: Bi, Bo
      – PersonEntity:
          Name:
            NameFull: Sun, Yuanlin
      – PersonEntity:
          Name:
            NameFull: Sun, Dong
      – PersonEntity:
          Name:
            NameFull: Chai, Jie
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 20011326
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Clinical & Translational Medicine
              Type: main
ResultId 1